168759-64-6

Usage

Uses

Used in Pharmaceutical Industry:
7-Bromo-4-isochromanone is used as a chemical intermediate for the synthesis of various biologically active molecules, contributing to the development of novel drugs and pharmaceutical compounds.
Used in Agrochemical Industry:
7-Bromo-4-isochromanone is used as a building block in the creation of new chemical entities for agrochemical applications, potentially leading to the development of innovative and effective agrochemical products.
Used in Organic Synthesis:
7-Bromo-4-isochromanone is used as a versatile precursor in organic synthesis, enabling the production of a wide range of chemical compounds with diverse applications across various industries.

InChI:InChI=1/C9H7BrO2/c10-7-1-2-8-6(3-7)4-12-5-9(8)11/h1-3H,4-5H2

Upstream product

• 67832-11-5 4-bromo-2-methylbenzonitrile 
• 457051-12-6 4-bromo-2-(bromomethyl)-benzonitrile 
• 19477-73-7 6-bromophthalide 
• 670256-21-0 4-bromo-2-(hydroxymethyl)benzoic acid 
• 64169-34-2 5-bromophthalide 
• 147034-01-3 (2,5-dibromophenyl)methanol 
• 76008-76-9 2,5-dibromobenzoic acid ethyl ester 

Downstream Products

• 1337154-53-6 7-bromoisochroman-4-amine 

Relevant academic research and scientific papers

HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF

The present invention relates to a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the treatment of various HAT-related diseases or conditions.

PPAR (peroxisome proliferator-activated receptor) agonist and application thereof to treatment of senile dementia and other diseases

The invention relates to a compound, namely a gamma-subtype peroxisome proliferator-activated receptor (PPAR) agonist. In addition, the invention discloses a medicinal component and a preparation containing the compound and application of such the gamma-subtype PPAR agonist.

ALDOSTERONE SYNTHASE INHIBITORS

The present invention relates to compounds of the formulas (IA) and (IB) and pharmaceutically acceptable salts thereof, wherein A and R1 - R6, are as defined herein. The invention also relates to pharmaceutical compositions comprisin

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.